Cited by 108Abdominal vascular conditions and treatmentsSepsis Diagnosis and TreatmentAcute Kidney Injury Research

Biochemical markers of acute intestinal ischemia: Possibilities and limitations

Open access
Montagnana, Martina, Danese, Elisa, Lippi, Giuseppe·2018·Annals of Translational Medicine

Abstract

Acute intestinal ischemia is a relative rare abdominal emergency, associated with considerably high morbidity and mortality rates. Although the conventional diagnostic approach to acute intestinal ischemia entails a preliminary evaluation of signs and symptoms, followed by radiological and laboratory investigations, a definitive diagnosis is can usually be made after laparotomy, which still remains the gold standard diagnostic (and therapeutic) procedure. Several potential laboratory biomarkers have been investigated over the past decades, but none of these seems to reach a suitable diagnostic accuracy for an early and reliable diagnosis of intestinal ischemia. The aim of this narrative review is to provide an overview on traditional laboratory tests for diagnosing acute intestinal ischemia (i.e., complete blood count, D-dimer, blood gas analysis, total lactic acid, C-reactive protein and procalcitonin), and summarize current evidence regarding some emerging and potentially useful biomarkers such as D-lactate, intestinal fatty acid-binding protein (I-FABP), ischemia modified albumin (IMA), α-glutathione S-transferase (α-GST), interleukin-6 (IL-6), citrulline and smooth muscle protein of 22 kDa (SM22). Among the various tests, D-lactate, IMA and I-FABP are perhaps the most promising, since they are characterized by optimal sensitivity and relatively good specificity, early kinetics, and can be measured with assays suited for a rapid diagnosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.21037/atm.2018.07.22

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Higher D-lactate levels could be more specific for mesenteric ischemia due to increased bacterial proliferation at the level of the ischemic bowel, but the results obtained in different studies are mostly inconsistent.

    “Higher D-lactate levels could be more specific for mesenteric ischemia due to increased bacterial proliferation at the level of the ischemic bowel, but the results obtained in different studies are mostly inconsistent [53,54].”

    From Acute mesenteric ischemia in COVID-19 patients (2021) · cites this paper as [54]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 78 · Cited by 108

Research works printed but not linked: 3

  1. Powell A, Armstrong P. Plasma biomarkers for early diagnosis of acuteintestinal ischemia. Semin Vasc Surg 2014;27:170-5.
  2. Nutz V, Sommer HJ. Hyperlactacidemia in intestinal ischemia. I. Theoretical considerations (in German). Langenbecks Arch Chir 1987;370:63-8.
  3. Tan WW, Zhang M. Clinical value of D-dimer for early diagnosis and severity of ischemic bowel disease. Lab Med Clin 2016;13:1497-9.

Authors
Montagnana, M., Danese, E., & Lippi, G.
Affiliations
University of Verona (IT)
Corresponding author
Montagnana, Martina
Venue
Annals of Translational Medicine
Published
2018-09
Volume
6
Issue
17
Pages
341-341
ISSN
  • 2305-5839 (ISSN-L)
  • 2305-5847
OpenAlex
W2885860559
Cited by
108
References
78
Citations by year
2026: 7 · 2025: 17 · 2024: 10 · 2023: 23 · 2022: 16 · 2021: 18 · 2020: 11 · 2019: 6
FWCI
1.95
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Annals of Translational Medicine (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Padua Research Archive (University of Padova) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Abdominal vascular conditions and treatments
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
Keywords
acute mesenteric ischemia, biomarkers, laboratory diagnosis, D-lactate, intestinal fatty acid binding protein, ischemia-modified albumin, alpha-glutathione S-transferase, interleukin-6, citrulline, D-dimer, C-reactive protein, procalcitonin, blood gas analysis, diagnostic accuracy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review